Ashurst advises Arcmont and apoBank on financing the investment in Smile Eyes
11 August 2021
11 August 2021
Ashurst advised certain funds managed by Arcmont Asset Management Limited (Arcmont) and Deutsche Apotheker- und Ärztebank eG (apoBank) as lenders on the financing of the investment in Smile Eyes Group (Smile Eyes). The investment is structured as a partnership between Trilantic Europe, the two co-founders of Smile Eyes, Dr Martin Bechmann and Dr Rainer Wiltfang, and the management team. Arcmont acted as senior lender and apoBank as super senior lender.
Smile Eyes is a leading player in the German ophthalmology market with headquarters in Munich. The company stands for eye laser and lens surgery at the highest medical level and has a comprehensive service offering in the field of ophthalmology in various metropolitan regions in Germany.
Arcmont is a market-leading asset manager, providing flexible capital solutions to a wide range of businesses in Europe. Established in 2011 and previously part of BlueBay Asset Management, Arcmont is now an independent asset management firm managing approximately €17 billion of assets for institutional investors globally. Ashurst advises Arcmont and apoBank regularly in connection with the financing of leveraged buyouts.
Trilantic Europe is a pan-European private equity firm focusing on mid-market transactions in Europe. Trilantic’s sectors of focus are healthcare, consumer & leisure, industrials, TMT, and business services.
The Ashurst team advising Arcmont was led by partner Anne Grewlich and counsel Sabrina Bremer. They were assisted by counsel Gabrielle Metherall, senior associate Emilie Veyran-Müller, senior transaction manager Carina Gläßl (all Global Loans) and transaction lawyer Isabelle Renninger (Banking & Finance, all Frankfurt).
Ashurst's German banking and finance practice advises both banks and alternative lenders, private equity investors and companies on domestic and cross-border acquisition, real estate, asset and infrastructure / project finance as well as on financial restructuring and corporate lending.